JP Morgan Chase
ALT icon

JP Morgan Chase’s Altimmune ALT Stock Holding History

JP Morgan Chase’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,900
Closed -$61.5K – 7368
2025
Q2 		$61.5K Buy
+15,900
New +$86K ﹤0.01% 5837
2024
Q2 		– Sell
-49,300
Closed -$502K – 7319
2024
Q1 		$502K Buy
+49,300
New +$501K ﹤0.01% 4795
2022
Q4 		– Sell
-37,200
Closed -$475K – 6513
2022
Q3 		$475K Buy
+37,200
New +$549K ﹤0.01% 4499

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's ALT Position: Q2 2026 in Review

JP Morgan Chase reduced its Altimmune (ALT) stake by 16% in Q2 2026, selling an estimated $62.3K and leaving 106,625 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #5368.

JP Morgan Chase first reported a position in ALT in Q4 2016 and has held it in 28 quarters since. The position peaked at $8.31M in Q3 2022. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • JP Morgan Chase held 106,625 shares of Altimmune worth $313K as of Q2 2026.
  • JP Morgan Chase sold 20,873 Altimmune shares in Q2 2026, an estimated $62.3K.
  • Altimmune made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5368 holding.
  • JP Morgan Chase first reported a position in Altimmune in Q4 2016 and has held it in 28 quarters since.
  • JP Morgan Chase's Altimmune position peaked at $8.31M in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.